Indrin J. Chetty, PhD

Articles by Indrin J. Chetty, PhD

ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent

ByJoe Yujiao Chang, MD, PhD,Larry L. Kestin, MD,R. Bryan Barriger, MD,Indrin J. Chetty, PhD,Mark E. Ginsburg, MD,Sanath Kumar, MD,Billy W. Loo, Jr, MD, PhD,Benjamin Movsas, MD,Andreas Rimner, MD,Kenneth E. Rosenzweig, MD,Thomas E. Stinchcombe, MD,Gregory M. M. Videtic, MD, CM,Henning Willers, MD

August 15th 2014

The treatment of inoperable stage III non–small-cell lung cancer (NSCLC) remains a challenge due to high rates of distant metastasis, local recurrence, and toxicity associated with definitive therapy.

Latest Updated Articles

ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent
Published: August 15th 2014 | Updated:

Indrin J. Chetty, PhD

Articles by Indrin J. Chetty, PhD

ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent

Latest Updated Articles

Trending on CancerNetwork

The Essential Role of Clinical Social Work in Oncology

Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer

Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma

Intravesical Mitomycin Produces Enduring Efficacy Across NMIBC Trials

Dato-DXd Improves Survival in Recurrent Inoperable/Metastatic TNBC